Meghan Zubradt is Senior Manager of Transactions at the Johnson & Johnson Innovation Center in California. In this role, she is responsible for negotiating and securing deals for early-stage innovation, focused on opportunities in areas of strategic interest across the West North America, Australia and New Zealand region.
Meghan joined Johnson & Johnson Innovation from her previous role as the Director of Business Development at a UCSF-affiliated oncology start‐up, which develops bispecific antibodies for the treatment of solid tumors, and was responsible for the company’s long‐term strategy, fundraising efforts, project management, and legal. Previously, Meghan led alliance management and business development for the Office of Strategic Alliances at UCSF. Her portfolio spanned therapeutic areas with the strongest emphasis in oncology, immunology, and neuroscience, and she specialized in complex preclinical deals with multiple projects, partners, and universities, including the university’s largest publicly disclosed partnerships with Celgene/BMS, AbbVie, Amgen, Pfizer, and GSK.
Meghan received her Ph.D. in Biomedical Sciences from UCSF where she was a Genentech Fellow and NSF Graduate Research Fellow in the laboratory of Jonathan Weissman. She holds a BS in Biology from Brown University.